To read the full story, subscribe or sign in.

Value Creation is the Name of the Game in Bio Partnering

Sep. 20, 2012

BOSTON – From the welcoming remarks to the plenary session and workshops, the message to BioPharm America 2012 attendees was loud and clear: Partnering is all about value creation.

BioWorld

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 17, 2025.

New Trump order zeroes in on drug prices

BioWorld

In a blast from the past, U.S. President Donald Trump signed an executive order April 15 to deliver on his 2016 campaign promises and strengthen or reinstate...

ADPD 2025: Novel treatment modalities in neurodegenerative disorders

BioWorld Science

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...

Illustration of antibodies attacking nerve cells

Biohaven’s BHV-1310 shows promise for autoimmune disorders

BioWorld Science

Biohaven Pharmaceuticals Inc. has presented preclinical data on their novel bispecific degrader BHV-1310 for the potential treatment of autoimmune disorders. To...